Troubled Clavis reorganizes board in wake of PhIII failures; Bird flu campaign cost $6.5B in China;

@FierceBiotech: PR: Life sciences industry vet Stephane Bancel joins Flagship Ventures. Release | Follow @FierceBiotech

@JohnCFierce: Is Novartis seriously scouting for new Alzheimer's drug candidates? More | Follow @JohnCFierce

@RyanMFierce: John Reynders is leaving AstraZeneca for CIO gig at hot biotech startup Moderna. Release | What he's done | Follow @RyanMFierce

> Clavis Pharma has appointed board member Martin Nes as interim chairman of the board of directors. Nes replaces Anders P. Wiklund, who resigned effective 21 May, 2013. Clavis has been sorting out its future after its two drug programs desively failed in Phase III. Release

> Health authorities in China believe they have gained control over the H7N9 bird flu outbreak at a cost to the economy of $6.5 billion. Story

Medical Device News

@FierceMedDev: If you missed it, here's FierceDrugDelivery's special report on the future of nanotech drug delivery. Feature | Follow @FierceMedDev

@MarkHFierce: Is the campaign to repeal the medical device industry tax "narrow-minded and dishonest?" More | Follow @MarkHFierce

 @DamianFierce: Terumo has prevailed in patent lawsuit against Vascular Solutions. Article | Follow @DamianFierce

> Boston Scientific, Elixir make waves at EuroPCR 2013. More

> Given Imaging envisions FDA sign-off by Q4 for PillCam Colon capsule. Story

> Johns Hopkins team views two genes as postpartum depression predictors. DxExtra

Pharma News

@FiercePharma: Amag pulls anemia drug batch after Swiss patient dies. Report | Follow @FiercePharma

@EricPFierce: Pfizer's effort to avoid a shortage after recall of new formulation of Levoxyl backfires with second recall. Article | Follow @EricPFierce

> Merck to buy $5B in stock from Goldman Sachs in jump-start for repurchase plan. News

> Boehringer Ingelheim handed FDA warning letter. Report

> Pfizer offers share exchange to grant Zoetis its freedom. More

Drug Delivery News

@MichaelGFierce: Nanoparticles made from grapefruit lipids deliver drugs safely. More | Follow @MichaelGFierce

> Single-cell electroporation riddles cells with drug delivery holes. Article

> Elixir bolsters recent CE mark with successful pivotal trial. News

> Radioactive nanoparticles target, shrink metastasized lymphoma tumors. Story

> Alnylam records RNAi delivery success to treat rare disease. More

> FDA clears Oramed's oral insulin pill for PhII trials. Article

And Finally… A new study found that more than 40% of patients being treated for COPD at a federally funded clinic did not have the disease. Release

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.